Tadalafil, the active ingredient in Cialis, reaches peak levels in the bloodstream about 2 hours after taking it. That timing applies regardless of sex. However, there is no FDA-approved version of tadalafil for women’s sexual health, and the evidence that it improves female sexual function is limited. When women are prescribed tadalafil, it is entirely off-label, meaning a doctor has decided to try it based on its known effects on blood flow rather than on robust clinical data specific to women.
What “Female Cialis” Actually Means
There is no product called “female Cialis.” The term circulates online, but it refers to regular tadalafil being used off-label by women. Cialis is approved for erectile dysfunction and benign prostatic hyperplasia in men, and a version of tadalafil is approved for pulmonary arterial hypertension in both sexes. No regulatory agency has approved tadalafil for female sexual arousal disorder, low desire, or any other sexual concern in women.
The theory behind off-label use is straightforward: tadalafil relaxes smooth muscle and increases blood flow, which could improve genital arousal. In men, this mechanism is well proven. In women, the picture is far less clear. Clinical trials testing tadalafil for female sexual dysfunction have not produced strong enough results to earn approval, and the drug class as a whole is described in the medical literature as “promising” but “not strongly indicated” for women.
How Quickly Tadalafil Works in the Body
When swallowed as a tablet, tadalafil is absorbed and reaches its highest concentration in the blood roughly 2 hours later. That pharmacokinetic window is the same for men and women. In at least one clinical study involving women, researchers timed their measurements at 2 hours after dosing specifically because that is tadalafil’s known peak.
Unlike shorter-acting drugs in the same class, tadalafil stays active for a long time. Its effects can last up to 36 hours, which is why it earned the nickname “the weekend pill” in men’s health circles. For women experimenting with it off-label, this long window means a single dose does not need to be timed precisely before sexual activity.
Food has a minimal effect on absorption compared to similar medications, so taking it with or without a meal should not significantly change timing. A high-fat meal may slow absorption slightly, but the difference is small.
What the Research Shows in Women
Most studies on tadalafil in women have been small, and results have been mixed. One area where researchers have seen a measurable physical effect is blood flow and smooth muscle relaxation in the pelvic region. A crossover study gave women a single 40 mg dose and measured changes in urethral pressure 2 hours later, confirming that the drug does produce a physiological response in female tissue at peak concentration.
But physical blood flow and subjective sexual satisfaction are different things. Trials looking at whether women actually feel more aroused or enjoy sex more have not consistently shown a benefit over placebo. This disconnect between measurable blood flow changes and experienced desire or pleasure is a major reason tadalafil has never gained approval for female sexual dysfunction.
FDA-Approved Options for Women
Two medications are specifically approved for low sexual desire in premenopausal women, and they work through completely different mechanisms than tadalafil.
- Flibanserin (Addyi) acts on brain chemistry rather than blood flow. It adjusts serotonin signaling in a way that can gradually increase desire over weeks of daily use. It is a 100 mg pill taken every night at bedtime. This is not a take-before-sex drug. It requires consistent daily dosing, and most women need 4 to 8 weeks before noticing a difference.
- Bremelanotide (Vyleesi) is an as-needed option. It is a self-administered injection given in the thigh or abdomen about 45 minutes before anticipated sexual activity. It activates receptors in the brain involved in mood and sexual response, essentially working from the top down rather than targeting genital blood flow.
The key distinction is that both approved options target desire and brain-based arousal, while tadalafil targets the physical mechanics of blood flow. For many women with sexual concerns, the issue is more about desire, emotional connection, or hormonal changes than about genital blood flow alone, which may explain why tadalafil trials in women have been disappointing.
Side Effects to Be Aware Of
Tadalafil’s side effect profile is well documented from its approved uses. The most common effects occur in more than 1 in 100 people and include headaches, facial flushing, indigestion, nausea, a stuffy nose, and muscle aches. These tend to be mild and resolve on their own. Serious side effects are rare, occurring in fewer than 1 in 1,000 users.
Certain combinations are dangerous. Tadalafil must never be taken with nitrate medications (commonly prescribed for chest pain), because the combination can cause a severe, potentially life-threatening drop in blood pressure. The interaction is so significant that nitrates should be avoided for at least 48 hours after a dose of tadalafil. Alpha-blockers used for blood pressure can also cause problematic drops in blood pressure when combined with tadalafil. Drinking five or more alcoholic drinks alongside a dose raises the risk of dizziness and fainting from low blood pressure as well.
Some common medications can increase tadalafil’s concentration in your blood, including certain antibiotics, antifungals, and HIV medications. If you take any of these, the effective dose of tadalafil changes substantially, and the risk of side effects goes up. Women with significant kidney or liver problems also need dose adjustments or may need to avoid the drug entirely.
The Bottom Line on Timing
If a prescriber has recommended tadalafil off-label, expect it to reach full effect about 2 hours after you take it, with activity lasting up to 36 hours. But the more important question is whether it will produce the result you are looking for. The physical blood flow effects are real, but they have not reliably translated into improved sexual satisfaction in clinical studies on women. For concerns centered on desire rather than physical arousal, the approved alternatives work through entirely different pathways and may be a better match.